- DIRECTOR, INSTITUTE FOR CRITICAL CARE MEDICINE
- PROFESSOR | Surgery
- Surgical Critical Care - Surgery
- Hospital Affiliation
- The Mount Sinai Hospital
Critical Care Medicine
- Acute Abdomen
- Acute Renal Failure
- Adult Respiratory Distress Syndrome
- Arterial Blood Gases
- Aspiration Pneumonia
- Intubation And Mechanical Ventilation
- Peripherally Inserted Central Catheter
- Severe Acute Respiratory Syndrome
- Subarachnoid Hemorrhage
Residency, Internal Medicine
Fellowship, Critical Care
Mount Sinai Hospital
Kohl-Seth, R, Manasia, A, Oropello, J, Bassily-Marcus, A, Benjamin, E. Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults treated for Endotoxemia and Septic Shock, EUPHRATES.
Enteral Nutrition Protocol in the ICU: Achieving Goals With Better Strategy
Oropello JM, Benjamin E, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. A Phase 2 study to determine the efficacy of Sivelestat in patients with Acute Lung Injury
Benjamin E Kohli-Seth R, Oropello JM Manasia A, Hannon E, DelGiudice R, Hufanda J Benign postoperative hyperlactatemia in Neurosurgical Patients
Benjamin E, Oropello JM, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. Beginning and Ending Supportive therapy (BEST) for the Kidney Study
Oropello JM, Benjamin E, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. Phase 3 multicenter randomized placebo study of PHP in sepsis with Shock.
A Manasia, Benjamin E, Oropello JM, R. Kohli-Seth R DelGiudice, J Hufanda. Limited transthoracic echocardiography (TTE) by non-cardiologist surgical intensivists.
Oropello JM, Benjamin E, Manasia A, R. Kohli-Seth R, DelGiudice, J Hufanda. J4A-MC-EZZI. A phase 2b Study to determine the efficacy and safety of LY315920 in patients with severe sepsis.
Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic shock (EUPHRATES)
The purpose of this study is to test a blood filtering device called a PMX cartridge which contains an antibiotic called Polymyxin B, plus standard of care treatment for sepsis and compare it to standard of care treatment alone. Patients who have a medical condition called septic...
Kohli-Seth R, Oropello JM. The future of bedside monitoring. Crit Care Clin 2000 October; 16(4): 557-578.
Killu K, Oropello JM, Manasia AR, Kohli-Seth R, Bassily-Marcus A, Leibowitz A, DelGiudice R, Murgolo V, Benjamin E. Effect of lower limb compression devices on thermodilution cardiac output measurement. Critical care medicine 2007 May; 35(5).
Kohli-Seth R, Neuman T, Sinha R, Bassily-Marcus A. Use of echocardiography and modalities of patient monitoring of trauma patients. Current opinion in anaesthesiology 2010 Apr; 23(2).
Frequency and Outcomes of Hyperlactatemia after Neurosurgery – A retrospective analysis. ICU Director 2011; 2(2).
Bassily-Marcus A, Oropello J, Shaik A, Kohli-Seth R, Manasia A, Benjamin E. Shifting Pneumothorax, A Radiographic and Sonographic Evaluation. ICU director 2011; 2(5).
Bassily-Marcus AM, Yuan C, Oropello J, Manasia A, Kohli-Seth R, Benjamin E. Pulmonary hypertension in pregnancy: critical care management. Pulmonary medicine 2012; 2012.
Wilson S, Kohli-Seth R, Aldeguer Y, Pek M, Dharshan A, Oropello J, Manasia A, Bassily-Marcus A, Benjamin E. Parenteral Nutrition Utilization in Bone Marrow Transplant Recipients.. Journal of Nutrition Health 2014;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Kohli-Seth did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.